BiotechTube
Home/Infant Bacterial Therapeutics AB/Mikael G. Engdahl
MG

Mikael G. Engdahl

Chief Financial Officer (CFO)

Infant Bacterial Therapeutics AB

Therapeutic Areas

NeonatologyGastroenterologyMicrobiome

Infant Bacterial Therapeutics AB Pipeline

DrugIndicationPhase
IBP-9414Prevention of Necrotizing Enterocolitis (NEC) and improvement of feeding tolerance in very low birth weight preterm infantsPhase 3

Leadership Team at Infant Bacterial Therapeutics AB

SS
Staffan Strömberg
Chief Executive Officer (CEO)
CS
Catharina Svanborg
Chairman of the Board
JA
Jan Andersson
Board Member
FL
Frida Lundgren
Board Member
JJ
Jonas Jendi
Board Member
KW
Karin Wingstrand
Board Member
View full Infant Bacterial Therapeutics AB profile